Get ready for a riveting discussion on Global Market Bulletin TV as we sit down with Dr. Linda Marbán, the dynamic CEO of Capricor Therapeutics (NASDAQ: CAPR), a trailblazer in the field of biotechnology. This interview offers a rare glimpse into the mind of a leader whose work is at the forefront of cell and exosome-based therapeutic developments aimed at combating muscular diseases and beyond.
What to Expect
In this exclusive interview, Dr. Marbán will shed light on several key topics, including:
- Upcoming Type-B Clinical Meeting: Hear firsthand about Capricor’s anticipated meeting with the U.S. Food and Drug Administration (FDA), a significant step as the company advances through the regulatory landscape.
- HOPE-3 Phase 3 Clinical Trial: Discover the latest on CAP-1002 in Duchenne Muscular Dystrophy (DMD) and its potential to make a profound impact on those affected by this challenging condition.
- StealthX™ Exosome Platform: Dive into the innovative world of exosome technology and how Capricor’s platform is paving the way for next-generation vaccines and therapeutics.
This conversation promises to be an invaluable resource for anyone interested in the cutting-edge of medical science, offering insights into the challenges, breakthroughs, and future of biotechnology.
Meet Dr. Linda Marbán
Dr. Marbán stands at the helm of Capricor Therapeutics, bringing over two decades of experience in the biotech realm. Her journey from academic science to leading one of the most innovative companies in biotechnology is nothing short of inspiring. Dr. Marbán’s extensive background, encompassing research, product development, and business strategy, positions her as a luminary in the field.
About Capricor Therapeutics
Capricor Therapeutics is not just a company; it’s a beacon of hope for those affected by muscular and select diseases. With its flagship cell therapy, CAP-1002, leading the charge in the battle against Duchenne Muscular Dystrophy, Capricor embodies the spirit of innovation. The company’s foray into exosome technology represents the frontier of therapeutic development, with the potential to revolutionize how we approach treatment for a myriad of conditions.
Tune In
Don’t miss this enlightening conversation with Dr. Linda Marbán. Set a reminder, mark your calendars, and join us on Global Market Bulletin TV for an interview that promises to broaden your horizons on the potential of biotechnology to transform lives.
Stay informed, stay inspired.
